CAJ | 학술논문

目的：观察尤瑞克林对恶性大脑中动脉梗死的疗效。方法30例恶性大脑中动脉梗死患者分成治疗组及对照组，对2组患者治疗后7 d、14 d后神经功能缺损评分、实验室指标变化和临床治疗总有效率进行比较。结果治疗组与对照组比较，神经功能缺损评分、临床总有效率均有显著性差异（P<0.05）。结论尤瑞克林对恶性大脑中动脉梗死具有较好的疗效，可作为临床治疗上一个新的选择参考。
목적：관찰우서극림대악성대뇌중동맥경사적료효。방법30례악성대뇌중동맥경사환자분성치료조급대조조，대2조환자치료후7 d、14 d후신경공능결손평분、실험실지표변화화림상치료총유효솔진행비교。결과치료조여대조조비교，신경공능결손평분、림상총유효솔균유현저성차이（P<0.05）。결론우서극림대악성대뇌중동맥경사구유교호적료효，가작위림상치료상일개신적선택삼고。
Objective The efficacy of Urinary Kallidinogenase in treating patients with Malignant middle cerebral artery infarction have been observed. Methods 30patients diagnosed to have suffered Malignant middle cerebral artery infarction were distributed to 2 groups randomly,the treatment group, the control group,The patients have been evaluated by the total effective rate,neurological deficit scores at day 7,14 after initiating the therapy. Results There are a significant improvement in the total effective rate,neurological deficit scores for the treatment group comparing with the control group(P<0.01,P<0.05).Conclusion Kallidinogenase injection showed a better therapeutic effect in patients with malignant middle cerebral artery infarction. It can be a new reference election. However ,the exact efficacy needs further RCT clinical trials.